RIZMOIC 200 MICROGRAMS FILM-COATED TABLETS
How to use RIZMOIC 200 MICROGRAMS FILM-COATED TABLETS
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the Patient
Rizmoic 200 micrograms film-coated tablets
naldemedine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the pack
- What is Rizmoic and what is it used for
- What you need to know before you take Rizmoic
- How to take Rizmoic
- Possible side effects
- Storage of Rizmoic
- Contents of the pack and other information
1. What is Rizmoic and what is it used for
Rizmoic contains the active substance naldemedine.
It is a medicine used in adults to treat constipation caused by analgesics, called opioids (e.g. morphine, oxycodone, fentanyl, tramadol, codeine, hydromorphone, methadone).
Your opioid analgesic may cause you to have the following symptoms:
- decreased frequency of bowel movements
- hard stools;
- stomach pain;
- rectal pain when passing hard stools;
- feeling that the bowel is not empty after passing stools.
Rizmoic can be used in patients who use an opioid for cancer pain or long-term non-cancer pain after they have previously been treated with a laxative.
2. What you need to know before you take Rizmoic
Do not take Rizmoic:
- if you are allergic to naldemedine or any of the other ingredients of this medicine (listed in section 6);
- if you have a blockage or perforation of the intestine, or if there is a high risk of intestinal blockage, as the blockage can cause a hole in the wall of the intestine.
Do nottake this medicine if any of the above applies to you. If in doubt, consult your doctor or pharmacist before taking Rizmoic.
Warnings and precautions
Consult your doctor or pharmacist before taking Rizmoic:
- if you have a disease that can affect the intestinal wall, such as:
- a stomach ulcer;
- enlarged colon due to a disease called Ogilvie's syndrome;
- diverticulitis (a disease in which there is inflammation of the intestine);
- intestinal or peritoneal cancer. The peritoneum is the lining of the intestine;
- a disease that causes severe inflammation of the digestive tract, such as Crohn's disease.
- if you have brain or central nervous system cancer, multiple sclerosis, or Alzheimer's disease. If you have these diseases and experience symptoms of opioid withdrawal (see section 4) or if the opioid stops providing you with pain control, contact your doctor immediately;
- if you have had a heart attack, stroke, or transient ischemic attack in the last 3 months. Your doctor should monitor you if you take Rizmoic;
- if you have severe liver disease, such as alcoholic liver disease, viral liver infection, or liver failure. Rizmoic should not be used in these patients;
- if you are taking certain medicines such as itraconazole to treat fungal infections, or an antibiotic called rifampicin to treat tuberculosis and other infections. See "Other medicines and Rizmoic".
If any of the above applies to you, or if in doubt, consult your doctor or pharmacist before taking Rizmoic.
Consult your doctor or pharmacist immediately while taking Rizmoic:
- if you experience severe, persistent, or worsening stomach pain, as it may be a symptom of developing a hole in the wall of the intestine and can be life-threatening.
Consult your doctor or pharmacist immediately and stop taking Rizmoic;
- if you experience symptoms of opioid withdrawal(see section 4 Posible side effects) that may appear between a few minutes and several days after taking a medicine like Rizmoic. Stop taking Rizmoic and contact your doctor if you experience symptoms of opioid withdrawal;
- if you experience severe diarrhea or severe stomach pain, inform your doctor, so that they can monitor you and treat you with rehydration and appropriate medications if necessary.
Children and adolescents
This medicine should not be used in children and adolescents under 18 years of age, as the effects of the medicine in children and adolescents are unknown.
Other medicines and Rizmoic
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Consult your doctor or pharmacist if you are taking any of the following medicines:
- rifampicin, clarithromycin, or telithromycin (antibiotics);
- itraconazole or ketoconazole (medicines used to treat fungal infections);
- ritonavir, indinavir, or saquinavir (medicines for HIV infection);
- phenytoin, carbamazepine, phenobarbital (medicines used to treat epilepsy);
- St. John's Wort (Hypericum perforatum), a herbal medicine used for depression;
- cyclosporin, a medicine used in transplant patients or to treat rheumatoid arthritis.
Using these medicines with Rizmoic may affect how naldemedine works or may increase its side effects.
Rizmoic with drinks
Do not drink large amounts of grapefruit juice while taking Rizmoic. If you do, you may have too much naldemedine in your blood and may experience more side effects (possible side effects are listed in section 4).
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. The effects of the medicine in pregnant women are unknown. Using Rizmoic during pregnancy may cause opioid withdrawal syndrome in the baby (see section 4). Your doctor will advise you whether you can take Rizmoic if you are pregnant.
Do not breastfeed while taking Rizmoic, as it is unknown whether naldemedine passes into breast milk. Consult your doctor if you are already breastfeeding.
Driving and using machines
Rizmoic has no influence on the ability to drive and use machines.
Rizmoic contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
3. How to take Rizmoic
Take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
- The recommended dose is one 200 microgram tablet once a day.
- You can take Rizmoic with or without laxatives.
- You can take Rizmoic at any time of day, with or without food. However, once you start taking the medicine, take it at approximately the same time every day.
- No dose adjustment of your opioid is needed before starting Rizmoic.
If you stop taking your opioid
Your doctor will advise you to stop taking Rizmoic when you stop taking your opioid analgesic. Consult your doctor or pharmacist before stopping treatment with Rizmoic to avoid worsening symptoms.
If you take more Rizmoic than you should
If you have taken more Rizmoic than you should, talk to a doctor or go to a hospital. They will monitor you for symptoms of opioid withdrawal (see section 2, under "Warnings and precautions", and section 4).
If you forget to take Rizmoic
If you forget to take a Rizmoic tablet, take it as soon as you remember.
However, if it is less than 12 hours until your next dose, skip the missed dose and wait until it is time to take the next tablet.
Do not take a double dose to make up for a forgotten dose.
If you stop taking Rizmoic
Stopping Rizmoic while continuing to take your opioid may cause you to have constipation again. Inform your doctor if you stop taking Rizmoic.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most serious side effects seen in patients taking Rizmoic have been symptoms of opioid withdrawal. This side effect is uncommon (may affect up to 1 in 100 people).
Stop taking Rizmoic and contact your doctor if you experiencea combination of 3 or more of the following symptoms of opioid withdrawalon the same day:
- Depression
- nausea (feeling sick) or vomiting
- muscle pain
- tearful eyes or runny nose
- dilated pupils
- gooseflesh
- sweating
- diarrhea
- yawning
- fever
- inability to sleep
The following side effects may occur with this medicine:
If you are being treated with an opioid for chronic non-cancer pain.
Rare (may affect up to 1 in 1,000 people):
- If you experience a severe allergic reaction, stop taking Rizmoic and go to a doctor or hospital immediately. Severe allergic reactions include: swelling of the hands, feet, ankles, face, lips, or throat which may cause difficulty in swallowing or breathing, itching of the skin, and hives.
Common (may affect up to 1 in 10 people):
- Diarrhea
- stomach pain
- nausea (feeling sick)
- vomiting
If you are being treated with an opioid for cancer.
Very common (may affect more than 1 in 10 people):
- diarrhea
Common:
- stomach pain
If you are being treated with an opioid for cancer or chronic non-cancer pain.
Frequency not known (cannot be estimated from the available data):
- gastrointestinal perforation (a hole that develops in the wall of the intestine)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Rizmoic
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP. The expiry date is the last day of the month stated.
Store in the original package to protect the tablets from light and moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and other information
What Rizmoic contains
- Each tablet contains 200 micrograms of naldemedine (as tosilate).
- The other ingredients are:
Core of the tablet: mannitol, sodium croscarmellose (see section 2 under "Rizmoic contains sodium") and magnesium stearate.
Film coating: hypromellose, talc, and yellow iron oxide (E172).
Appearance and packaging
Rizmoic is a film-coated tablet, round, approximately 6.5 mm in diameter, yellow, with the inscription "222" and the Shionogi logo on one side and "0.2" on the other.
This medicine is available in aluminum blisters containing 7, 10, or 14 tablets.
Package sizes of 7, 10, 28, 30, 84, or 100 tablets.
This medicine is also available in single-dose aluminum blisters containing 10 tablets.
Package sizes of 30 x 1 tablet in single-dose blisters.
Not all pack sizes may be marketed in your country.
Marketing authorisation holder
Shionogi B.V.
Herengracht 464
1017CA Amsterdam
Netherlands
Manufacturer
Shionogi B.V.
Herengracht 464
1017CA Amsterdam
Netherlands
You can get more information on this medicine by contacting the local representative of the marketing authorisation holder:
AT, BG, CY, CZ, EE, IE, EL, HR, HU, IE, IS, LT, LV, MT, PT, RO, SI, SK Shionogi B.V. Tel/Tel./Te?./Tlf/Tél/Puh/Sími/Τηλ: +31204917439 | DE Viatris Healthcare GmbH Tel: +49 800 0700 800 |
ES Casen Recordati, S.L. Tel: +34 91 659 15 50 | IT Shionogi Srl Tel: +39 06 94 805 118 |
UK(NI) Sandoz Limited Tel: +44 (0)1276 698020 | FR Viatris Santé Tél: +33 (0)1 40 80 15 55 |
PL Molteni Farmaceutici Polska Sp. z o.o Tel.: +48 (12) 653 15 71 e-mail: [email protected] | SE Viatris AB Tel: + 46 (0)8 630 19 00 |
DK Viatris ApS Tlf: +45 28 11 69 32 | FI Viatris Oy Puh/Tel: +358 20 720 9555 |
NO Viatris AS Tlf: + 47 66 75 33 00 | BE & LU Viatris Tel/Tél: + 32 (0)2 658 61 00 |
NL Mylan Healthcare B.V. Tel: +31 (0)20 426 33 00 |
Date of last revision of this leaflet:
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/.
- Country of registration
- Average pharmacy price80.08 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to RIZMOIC 200 MICROGRAMS FILM-COATED TABLETSDosage form: TABLET, 12.5 mgActive substance: naloxegolManufacturer: Grünenthal GmbhPrescription requiredDosage form: TABLET, 25 mgActive substance: naloxegolManufacturer: Grünenthal GmbhPrescription requiredDosage form: INJECTABLE, 12 mgActive substance: methylnaltrexone bromideManufacturer: Bausch Health Ireland LimitedPrescription required
Online doctors for RIZMOIC 200 MICROGRAMS FILM-COATED TABLETS
Discuss questions about RIZMOIC 200 MICROGRAMS FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions
